FDC Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: FDC BSE: 531599

₹339.40

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #58 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
FDC Limited (this stock)	5,526	18.7	11.3%	-25.8%	1.47%	79	47	47

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹5,488 Cr

EV / EBITDA

12.0x

EV / Sales

2.57x

Market cap / Sales

2.58x

Earnings yield

5.35%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 702 Cr, up 3.6% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 132 Cr, up 8.0% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	655	174	132	₹8.1100
March 31, 2026	564	143	107	₹6.5800
Dec. 31, 2025	458	35	27	₹1.6700
Sept. 30, 2025	462	39	29	₹1.8100
June 30, 2025	642	161	122	₹7.5100
March 31, 2025	482	68	48	₹2.9600
Dec. 31, 2024	459	50	36	₹2.2400
Sept. 30, 2024	505	92	74	₹4.5500
June 30, 2024	624	158	115	₹7.0600
March 31, 2024	454	67	48	₹2.9700
Dec. 31, 2023	452	96	78	₹4.8100
Sept. 30, 2023	480	95	72	₹4.3600
June 30, 2023	530	139	109	₹6.5400

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	702	612	480	483	678	513	478	540	652	475	478	507	560
Operating revenue	655	564	458	462	642	482	459	505	624	454	452	480	530
Other income	47	47	22	21	36	31	19	35	28	21	25	27	30
Operating expenses	512	453	408	427	501	429	413	433	482	396	370	401	410
Operating profit	143	112	50	35	141	53	46	72	142	58	82	79	120
Operating profit margin	21.8%	19.8%	10.8%	7.6%	22.0%	11.0%	10.0%	14.3%	22.7%	12.7%	18.1%	16.4%	22.6%
Depreciation	15	14	15	15	15	16	13	14	11	10	10	10	10
Interest	1	1	1	1	1	1	1	1	1	1	1	1	1
Exceptional items, gain / (loss)	—	—	-21	—	—	—	—	—	—	—	—	—	—
Profit before tax	174	143	35	39	161	68	50	92	158	67	96	95	139
Tax	42	36	8	10	39	19	14	18	43	19	18	23	31
Net profit	132	—	27	29	122	—	36	74	115	48	78	72	109
EPS	8.11	6.58	1.67	1.81	7.51	2.96	2.24	4.55	7.06	2.97	4.81	4.36	6.54
Net profit (TTM)	—	—	—	—	—	—	274	316	314	307	296	257	236
EPS (TTM)	18.17	17.57	13.95	14.52	17.26	16.81	16.82	19.39	19.20	18.68	17.95	15.52	14.23

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	2,126	378	286
March 31, 2025	2,070	368	274
March 31, 2024	1,916	398	307
March 31, 2023	1,777	266	201

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	6.7%	9.5%	2,252^†	2,183^†	2,019^†	1,854^†	1,598^†	1,430^†	1,440^†	1,132^†	1,132^†	1,094^†
Operating revenue	6.2%	9.9%	2,126	2,070	1,916	1,777	1,519^†	1,325^†	1,331^†	1,076^†	1,070^†	1,044^†
Other income	—	—	126^†	113^†	103^†	77^†	79^†	104^†	109^†	57^†	62^†	50^†
Operating expenses	—	—	1,789^†	1,757^†	1,578^†	1,545^†	1,272^†	1,008^†	1,074^†	858^†	862^†	—
Operating profit	13.4%	1.2%	337^†	313^†	338^†	232^†	247^†	317^†	257^†	218^†	208^†	—
Operating profit margin	—	—	15.9%^†	15.1%^†	17.7%^†	13.0%^†	16.3%^†	23.9%^†	19.3%^†	20.3%^†	19.4%^†	—
Depreciation	—	—	59^†	54^†	40^†	39^†	37^†	38^†	37^†	33^†	35^†	35^†
Interest	—	—	5^†	4^†	4^†	4^†	3^†	3^†	3^†	1^†	1^†	—
Exceptional items, gain / (loss)	—	—	-21^†	0^†	0^†	0^†	0^†	0^†	-0^†	-4^†	0^†	-6^†
Profit before tax	12.5%	-0.1%	378	368	398	266	285^†	380^†	325^†	236^†	234^†	250^†
Tax	—	—	92^†	94^†	91^†	65^†	66^†	86^†	79^†	65^†	66^†	63^†
Net profit	12.5%	-0.6%	286	274	307	201	220^†	294^†	247^†	172^†	168^†	187^†
EPS	13.4%	0.3%	17.57^†	16.81^†	18.68^†	12.06^†	13.01^†	17.30^†	14.30^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	15.9%^†	15.1%^†	17.7%^†	13.0%^†	16.3%^†	23.9%^†	19.3%^†	20.3%^†	19.4%^†	—
EBIT margin	18.0%^†	18.0%^†	21.0%^†	15.2%^†	19.0%^†	29.0%^†	24.7%^†	22.1%^†	22.0%^†	—
PBT margin	17.8%	17.8%	20.8%	15.0%	18.8%^†	28.7%^†	24.5%^†	22.0%^†	21.9%^†	23.9%^†
Net margin	13.4%	13.2%	16.0%	11.3%	14.5%^†	22.2%^†	18.5%^†	15.9%^†	15.7%^†	17.9%^†
Interest coverage	77.84x^†	82.92x^†	100.49x^†	66.79x^†	94.65x^†	112.82x^†	96.31x^†	166.02x^†	167.77x^†	—
Dividend payout	28.5%^†	29.7%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	5.6%^†	—	—	—
Earnings retention	71.5%^†	70.3%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	94.4%^†	—	—	—
Current ratio	3.13x	3.00x	—	—	—	—	—	—	—	—
Quick ratio	2.16x	1.96x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—	—
Return on equity	11.5%	12.0%	—	—	—	—	—	—	—	—
Return on assets	9.8%	10.1%	—	—	—	—	—	—	—	—
Return on capital employed	15.0%^†	15.8%^†	—	—	—	—	—	—	—	—
Asset turnover	0.73x	0.76x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	200	-109	-93	186	14
March 31, 2025	310	-199	-92	97	214
March 31, 2024	221	-18	-202	93	127
March 31, 2023	165	4	-180	116	49
March 31, 2022	162	-147	-10	132	30

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	2,912	2,493	2,476	0	0	1,109	354	37	948	344
March 31, 2025	2,710	2,287	2,271	0	0	1,065	355	40	844	368
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.